• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

EBioMedicine . Large-scale computational modelling of H5 influenza variants against HA1-neutralising antibodies

tetano

Editor, Senior Moderator
EBioMedicine


. 2025 Mar 17:114:105632.
doi: 10.1016/j.ebiom.2025.105632. Online ahead of print. Large-scale computational modelling of H5 influenza variants against HA1-neutralising antibodies

Colby T Ford[SUP] 1 [/SUP], Shirish Yasa[SUP] 2 [/SUP], Khaled Obeid[SUP] 2 [/SUP], Rafael Jaimes 3rd[SUP] 3 [/SUP], Phillip J Tomezsko[SUP] 3 [/SUP], Sayal Guirales-Medrano[SUP] 2 [/SUP], Richard Allen White 3rd[SUP] 4 [/SUP], Daniel Janies[SUP] 5 [/SUP]



Affiliations
Abstract

Background: The United States Department of Agriculture has recently released reports that show samples collected from 2022 to 2025 of highly pathogenic avian influenza (H5N1) have been detected in mammals and birds. Up to February 2025, the United States Centres for Disease Control and Prevention reports that there have been 67 humans infected with H5N1 since 2024 with 1 death. The broader potential impact on human health remains unclear.
Methods: In this study, we computationally model 1804 protein complexes consisting of various H5 isolates from 1959 to 2024 against 11 haemagglutinin domain 1 (HA1)-neutralising antibodies. This was performed using AI-based protein folding and physics-based simulations of the antibody-antigen interactions. We analysed binding affinity changes over time and across various antibodies using multiple biochemical and biophysical binding metrics.
Findings: This study shows a trend of weakening binding affinity of existing antibodies against H5 isolates over time, indicating that the H5N1 virus is evolving immune escape from our therapeutic and immunological defences. We also found that based on the wide variety of host species and geographic locations in which H5N1 was observed to have been transmitted from birds to mammals, there is not a single central reservoir host species or location associated with H5N1's spread.
Interpretation: These results indicate that the virus has potential to move from epidemic to pandemic status. This study illustrates the value of high-performance computing to rapidly model protein-protein interactions and viral genomic sequence data at-scale for functional insights into medical preparedness.
Funding: No external funding was used in this study.

Keywords: Antibodies; Avian influenza; Docking; Protein modelling; Zoonosis.

 
Back
Top Bottom